450
Participants
Start Date
January 22, 2019
Primary Completion Date
October 4, 2019
Study Completion Date
October 4, 2019
ROTAVAC®
0.5 ml of the vaccine will be administered orally thrice at 6, 10 and 14 weeks of age.
ROTAVAC 5D
0.5 ml of the vaccine will be administered orally thrice at 6, 10 and 14 weeks of age.
Rotarix®
1.5 ml of the liquid vaccine will be administered orally twice at 6 and 10 weeks of age.
George Research Centre, Lusaka
PATH
OTHER
Christian Medical College, Vellore, India
OTHER
Children's Hospital Medical Center, Cincinnati
OTHER
Bharat Biotech International Limited
INDUSTRY
Centre for Infectious Disease Research in Zambia
OTHER